Stay updated on Pembrolizumab Skin Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Skin Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Skin Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.1%
    Check dated 2025-06-13T16:29:19.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T10:07:21.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-30T04:51:01.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-23T02:12:53.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:20:34.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new collaborators and identifiers related to a clinical trial for recurrent skin carcinoma, while also removing detailed information about the trial's objectives and treatment protocols.
    Difference
    55%
    Check dated 2025-04-16T20:27:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Skin Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Skin Cancer Clinical Trial page.